None listed
Conditions
Interventions
Intervention1: Stable isotope labelled Beta carotene and Retinyl acetate: Dual isotopic dose of 13C10 beta- Carotene (2mg/ml) and D4 Retinyl acetate dose (1mg/ml)in sunflower oil will be given on the
Sponsors
Department of Biotechnology Government of India India Alliance
Eligibility
Inclusion criteria
Inclusion criteria: Six healthy male and females with no chronic and acute illness for the last 3 months and with normal blood biochemistry.
Exclusion criteria
Exclusion criteria: Those who are pregnant, smoking, or with high blood pressure, diabetes and with BMI greater than 30 kg/m2 or with liver/kidney/gastrointestinal disease, lipid metabolic disorders, and consuming multivitamin (containing vitamins A, C, E) or beta -carotene supplements 3 months prior to the study start.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Beta carotene bioconversion efficiencyTimepoint: One time measurement with biospecimen collection at day 0, 1, 2, 7 and 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| vitamin A statusTimepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr Sarita Devi
St. Johns Research Institute
Outcome results
None listed